Visionflex Group Limited (ASX:VFX)
Australia · Delayed Price · Currency is AUD 0.0020
0.00 (0.00%)
At close: Oct 30, 2025
Visionflex Group Revenue
In the fiscal year ending June 30, 2025, Visionflex Group had annual revenue of 4.65M AUD, down -33.07%.
Revenue
4.65M
Revenue Growth
+21.41%
P/S Ratio
1.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 4.65M | -2.30M | -33.07% |
| Jun 30, 2024 | 6.95M | 4.37M | 169.11% |
| Jun 30, 2023 | 2.58M | -122.75K | -4.54% |
| Jun 30, 2022 | 2.71M | -2.74M | -50.32% |
| Jun 30, 2021 | 5.45M | 496.87K | 10.04% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |